← FDA Drug Approvals (Drugs@FDA)

REGADENOSON

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMS LTD · Approved 2022-05-23

Drug application

FDA Application #

ANDA214252

Application type

Abbreviated New Drug Application (Generic)

Brand name

REGADENOSON

Generic name

REGADENOSON

Active ingredients

REGADENOSON

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

IMS LTD

Manufacturer

International Medication Systems, Limited

First approval

2022-05-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown